Comparison of telomere length in patients with bone marrow failure syndromes and healthy controls

Aruna Barade,Kavitha M. Lakshmi,Anu Korula,Fouzia N. Abubacker,Uday P. Kulkarni,Aby Abraham,Vikram Mathews,Biju George,Eunice S. Edison
DOI: https://doi.org/10.1111/ejh.14173
2024-01-13
European Journal Of Haematology
Abstract:Introduction During normal aging, telomeric DNA is gradually lost in dividing somatic cells, and critically short telomeres lead to replicative senescence, apoptosis, or chromosomal instability. We studied telomere length in bone marrow failure syndromes (BMFS) compared to normal healthy population. Methods Peripheral blood was collected from the participants, and genomic DNA was extracted. Relative telomere length was measured using a quantitative polymerase chain reaction. Statistical analysis was performed using SPSS and GraphPad Prism 8.2 software. Results The median age of normal Indian population was 31 (0–60) years. As expected, telomere length (TL) showed a decline with age and no difference in TL between males and females. The median age of 650 patients with aplastic anemia (AA) was 30 (1–60) years. TL was significantly shorter in patients with AA compared to healthy controls (p
hematology
What problem does this paper attempt to address?